COVID-19 Recombinant Protein Vaccine Market - Global Outlook and Forecast 2022-2028

31 March 2022
ICT & Media
60 Pages
Report code : 24WT-6972546

COVID-19 Recombinant Protein Vaccine Market

1 Introduction to Research & Analysis Reports
1.1 COVID-19 Recombinant Protein Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global COVID-19 Recombinant Protein Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global COVID-19 Recombinant Protein Vaccine Overall Market Size
2.1 Global COVID-19 Recombinant Protein Vaccine Market Size: 2022 VS 2028
2.2 Global COVID-19 Recombinant Protein Vaccine Market Size, Prospects & Forecasts: 2022-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key COVID-19 Recombinant Protein Vaccine Players in Global Market
3.2 Global Companies COVID-19 Recombinant Protein Vaccine Product & Technology
4 Players Profiles
4.1 GSK
4.1.1 GSK Corporate Summary
4.1.2 GSK Business Overview
4.1.3 GSK COVID-19 Recombinant Protein Vaccine Product Offerings & Technology
4.1.4 GSK COVID-19 Recombinant Protein Vaccine R&D, and Plans
4.2 Johnson & Johnson
4.2.1 Johnson & Johnson Corporate Summary
4.2.2 Johnson & Johnson Business Overview
4.2.3 Johnson & Johnson COVID-19 Recombinant Protein Vaccine Product Offerings & Technology
4.2.4 Johnson & Johnson COVID-19 Recombinant Protein Vaccine R&D, and Plans
4.3 Sanofi
4.3.1 Sanofi Corporate Summary
4.3.2 Sanofi Business Overview
4.3.3 Sanofi COVID-19 Recombinant Protein Vaccine Product Offerings & Technology
4.3.4 Sanofi COVID-19 Recombinant Protein Vaccine R&D, and Plans
4.4 Novavax
4.4.1 Novavax Corporate Summary
4.4.2 Novavax Business Overview
4.4.3 Novavax COVID-19 Recombinant Protein Vaccine Product Offerings & Technology
4.4.4 Novavax COVID-19 Recombinant Protein Vaccine R&D, and Plans
4.5 Pukang Biologic Technology
4.5.1 Pukang Biologic Technology Corporate Summary
4.5.2 Pukang Biologic Technology Business Overview
4.5.3 Pukang Biologic Technology COVID-19 Recombinant Protein Vaccine Product Offerings & Technology
4.5.4 Pukang Biologic Technology COVID-19 Recombinant Protein Vaccine R&D, and Plans
4.6 Clover Biopharmaceuticals
4.6.1 Clover Biopharmaceuticals Corporate Summary
4.6.2 Clover Biopharmaceuticals Business Overview
4.6.3 Clover Biopharmaceuticals COVID-19 Recombinant Protein Vaccine Product Offerings & Technology
4.6.4 Clover Biopharmaceuticals COVID-19 Recombinant Protein Vaccine R&D, and Plans
4.7 Suzhou Yuzhibo Biotechnology
4.7.1 Suzhou Yuzhibo Biotechnology Corporate Summary
4.7.2 Suzhou Yuzhibo Biotechnology Business Overview
4.7.3 Suzhou Yuzhibo Biotechnology COVID-19 Recombinant Protein Vaccine Product Offerings & Technology
4.7.4 Suzhou Yuzhibo Biotechnology COVID-19 Recombinant Protein Vaccine R&D, and Plans
5 Sights by Region
5.1 By Region - Global COVID-19 Recombinant Protein Vaccine Market Size, 2023 & 2028
5.2 By Region - Global COVID-19 Recombinant Protein Vaccine Revenue, (2023-2028)
5.3 United States
5.3.1 Key Players of COVID-19 Recombinant Protein Vaccine in United States
5.3.2 United States COVID-19 Recombinant Protein Vaccine Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of COVID-19 Recombinant Protein Vaccine in Europe
5.4.2 Europe COVID-19 Recombinant Protein Vaccine Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of COVID-19 Recombinant Protein Vaccine in China
5.5.2 China COVID-19 Recombinant Protein Vaccine Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 by Type - Global COVID-19 Recombinant Protein Vaccine Market Size Markets, 2023 & 2028
6.2 Being Developed
6.3 Preclinical
6.4 Clinical I
6.5 Clinical II
7 Sights by Application
7.1 By Application - Global COVID-19 Recombinant Protein Vaccine Market Size, 2023 & 2028
7.2 Pharmaceutical And Biotechnology Companies
7.3 Hospital
7.4 Academic And Research Organizations
7.5 Other
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

Ask Our Expert

List of Tables
Table 1. COVID-19 Recombinant Protein Vaccine Market Opportunities & Trends in Global Market
Table 2. COVID-19 Recombinant Protein Vaccine Market Drivers in Global Market
Table 3. COVID-19 Recombinant Protein Vaccine Market Restraints in Global Market
Table 4. Key Players of COVID-19 Recombinant Protein Vaccine in Global Market
Table 5. Global Companies COVID-19 Recombinant Protein Vaccine Product & Technology
Table 6. GSK Corporate Summary
Table 7. GSK COVID-19 Recombinant Protein Vaccine Product Offerings
Table 8. Johnson & Johnson Corporate Summary
Table 9. Johnson & Johnson COVID-19 Recombinant Protein Vaccine Product Offerings
Table 10. Sanofi Corporate Summary
Table 11. Sanofi COVID-19 Recombinant Protein Vaccine Product Offerings
Table 12. Novavax Corporate Summary
Table 13. Novavax COVID-19 Recombinant Protein Vaccine Product Offerings
Table 14. Pukang Biologic Technology Corporate Summary
Table 15. Pukang Biologic Technology COVID-19 Recombinant Protein Vaccine Product Offerings
Table 16. Clover Biopharmaceuticals Corporate Summary
Table 17. Clover Biopharmaceuticals COVID-19 Recombinant Protein Vaccine Product Offerings
Table 18. Suzhou Yuzhibo Biotechnology Corporate Summary
Table 19. Suzhou Yuzhibo Biotechnology COVID-19 Recombinant Protein Vaccine Product Offerings
Table 20. By Region? Global COVID-19 Recombinant Protein Vaccine Revenue, (US$, Mn), 2023 & 2028
Table 21. By Region - Global COVID-19 Recombinant Protein Vaccine Revenue, (US$, Mn), 2023-2028
Table 22. By Type ? Global COVID-19 Recombinant Protein Vaccine Market Size, (US$, Mn), 2023 & 2028
Table 23. By Application? Global COVID-19 Recombinant Protein Vaccine Market Size, (US$, Mn), 2023 & 2028
List of Figures
Figure 1. COVID-19 Recombinant Protein Vaccine Segment by Type in 2021
Figure 2. COVID-19 Recombinant Protein Vaccine Segment by Application in 2021
Figure 3. Global COVID-19 Recombinant Protein Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global COVID-19 Recombinant Protein Vaccine Market Size: 2022 VS 2028 (US$, Mn)
Figure 6. Global COVID-19 Recombinant Protein Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. By Region - Global COVID-19 Recombinant Protein Vaccine Revenue Market Share, 2023-2028
Figure 8. By Type - Global COVID-19 Recombinant Protein Vaccine Revenue Market Share, 2023-2028
Figure 9. By Application - Global COVID-19 Recombinant Protein Vaccine Revenue Market Share, 2023-2028

SECURITY ASSURED payment image

Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research

Frequently Asked Questions ?

User License

A license granted to one user.
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
Multi user License
A license granted to multiple users.
Site License
A license granted to a single business site/establishment.
Corporate License, Global License
A license granted to all employees within organisation access to the product.

Delivery Time

Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

WHY CHOOSE US

Proactive We manage our resources 24/7 to identify issues and address them before they become problems
Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach 6 Major regions and 40+ countries level analysis accomplished
Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery